Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-27T10:27:05.242Z Has data issue: false hasContentIssue false
  • English
  • Français

Patients' knowledge and views of their depot neuroleptic medication

Published online by Cambridge University Press:  02 January 2018

R. Goldbeck ,
S. Tomlinson  and
J. Bouch
R. Goldbeck*
Affiliation:
Department of Psychological Medicine, Aberdeen Royal Infirmary, Aberdeen AB25 2ZH
S. Tomlinson
Affiliation:
Goldenhill Resource Centre, Clydebank
J. Bouch
Affiliation:
Goldenhill Resource Centre, Clydebank
*
∗Correspondence
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Aims and method

This study examined the attitudes and knowledge of patients regarding their depot neuroleptic medication. All patients were attending a community mental health centre in Clydebank, Scotland.

Results

Many patients had limited knowledge of their medication, its benefits and side-effects as well as the rationale for its use. The biggest gaps were found in patients' knowledge of the long-term side-effects of their medication.

Clinical implications

Our findings raise doubts as to the capacity of some patients to give informed consent to their treatment. A number of steps are outlined in order to raise patients' standard of knowledge.

Type
Original Papers
Information
Psychiatric Bulletin , Volume 23 , Issue 8: The Journal of Trends in Psychiatric Practice , August 1999 , pp. 467 - 470
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1999 The Royal College of Psychiatrists

References

Brabbins, C., Butler, J. & Bentall, R. (1996) Consent to neuroleptic medication for schizophrenia: clinical, ethical and legal issues. British Journal of Psychiatry, 188, 540 544.CrossRefGoogle Scholar
Clary, C., Dever, A. & Schweizer, E. (1992) Psychiatric inpatients' knowledge of medication at hospital discharge. Hospital and Community Psychiatry, 43, 140 144.Google ScholarPubMed
Geller, J. L. (1982) State hospital patients and their medication – do they know what they take? American Journal of Psychiatry, 139, 611 615.Google ScholarPubMed
Kemp, R., Kirov, G., Everitt, B., et al (1998) Randomised controlled trial of compliance therapy, 18–month follow-up. British Journal of Psychiatry, 172, 413 419.CrossRefGoogle ScholarPubMed
Kleinman, I., Schachter, D., Jeffries, J., et al (1993) Effectiveness of two methods of informing schizophrenic patients about neuroleptic medication. Hospital and Community Psychiatry, 44, 1189 1191.Google ScholarPubMed
MacPherson, R., Jerrom, B. & Hughes, A. (1996) A controlled study of education about drug treatment in schizophrenia, British Journal of Psychiatry, 188. 709 717.CrossRefGoogle Scholar
Marinker, M. (1997) Personal paper: Writing prescriptions is easy. British Medical Journal, 314, 747 748.CrossRefGoogle ScholarPubMed
Royal College of Psychiatrists (1993) Patient Factsheet. Depot Antipsychotic Medication: What You Should Know. London: Royal College of Psychiatrists.Google Scholar
Soskis, D. A. (1978) Schizophrenic and medical in-patients as informed drug consumers. Archives of General Psychiatry, 35, 645 647.CrossRefGoogle Scholar
Soskis, D. A. & Jaffe, R. L. (1979) Communicating with patients about antipsychotic drugs. Comprehensive Psychiatry, 20, 126 131.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.